Approval · Notice of Compliance 9818 · 2008
MINT-CEFPROZIL: Notice of Compliance 9818
Issued October 9, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9818
- Date
- October 9, 2008
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- New manufacturer and product name
- Therapeutic class
- Antibiotic
- Canadian reference product
- CEFZIL (Bristol-Myers Squibb Canada)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-CEFPROZIL | 02317389 | — |
Medicinal ingredients
- CEFPROZIL MONOHYDRATE 250 MG per 5ML